Amneal Pharmaceuticals (AMRX) Short Interest Ratio & Short Volume $8.07 +0.32 (+4.13%) (As of 12/17/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Amneal Pharmaceuticals Short Interest DataAmneal Pharmaceuticals (AMRX) has a short interest of 4.67 million shares, representing 3.69% of the float (the number of shares available for trading by the public). This marks a 4.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.2, indicating that it would take 4.2 days of the average trading volume of 1.38 million shares to cover all short positions.Current Short Interest4,670,000 sharesPrevious Short Interest4,480,000 sharesChange Vs. Previous Month+4.24%Dollar Volume Sold Short$38.62 millionShort Interest Ratio4.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares309,844,000 sharesFloat Size126,530,000 sharesShort Percent of Float3.69%Today's Trading Volume1,276,739 sharesAverage Trading Volume1,382,464 sharesToday's Volume Vs. Average92% Short Selling Amneal Pharmaceuticals? Sign up to receive the latest short interest report for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMRX Short Interest Over TimeAMRX Days to Cover Over TimeAMRX Percentage of Float Shorted Over Time Ad DTIWill the Nasdaq 100 crash?In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!Click here to get the details. Amneal Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20244,670,000 shares $38.62 million +4.2%3.7%4.2 $8.27 11/15/20244,480,000 shares $37.95 million +28.0%3.5%4.1 $8.47 10/31/20243,500,000 shares $29.65 million -16.3%2.9%2.9 $8.47 10/15/20244,180,000 shares $36.83 million -7.7%3.5%3.4 $8.81 9/30/20244,530,000 shares $37.69 million -2.4%3.8%3.5 $8.32 9/15/20244,640,000 shares $40.00 million +8.7%3.9%3.2 $8.62 Get the Latest News and Ratings for AMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20244,270,000 shares $36.98 million +0.2%3.6%2.9 $8.66 8/15/20244,260,000 shares $33.70 million -4.1%3.6%2.9 $7.91 7/31/20244,440,000 shares $32.55 million -3.3%4.0%3.1 $7.33 7/15/20244,590,000 shares $33.87 million +1.6%4.1%3 $7.38 6/30/20244,520,000 shares $28.70 million +24.9%4.1%2.9 $6.35 6/15/20243,620,000 shares $24.94 million +0.3%3.3%2.4 $6.89 5/31/20243,610,000 shares $24.11 million +17.6%3.3%2.3 $6.68 5/15/20243,070,000 shares $21.09 million +29.5%2.8%1.9 $6.87 4/30/20242,370,000 shares $14.34 million -15.4%2.3%1.5 $6.05 4/15/20242,800,000 shares $15.51 million +16.7%2.5%1.8 $5.54 3/31/20242,400,000 shares $14.54 million +15.9%2.2%1.6 $6.06 3/15/20242,070,000 shares $11.39 million +13.1%1.9%1.4 $5.50 2/29/20241,830,000 shares $10.10 million -12.9%1.7%1.2 $5.52 2/15/20242,100,000 shares $12.37 million -17.3%1.9%1.5 $5.89 1/31/20242,540,000 shares $13.59 million +1.6%2.3%1.9 $5.35 12/15/20232,650,000 shares $13.75 million -16.7%2.4%1.9 $5.19 11/30/20233,180,000 shares $13.71 million -12.2%5.8%2.5 $4.31 11/15/20233,620,000 shares $16.25 million +13.5%6.5%2.9 $4.49 10/31/20233,190,000 shares $12.33 million +4.3%3.1%2.6 $3.87 10/15/20233,060,000 shares $11.75 million -20.5%3.0%2.4 $3.84 9/30/20233,850,000 shares $16.25 million +4.3%3.7%3.4 $4.22 9/15/20233,690,000 shares $15.17 million +1.9%3.6%3.4 $4.11 8/31/20233,620,000 shares $14.81 million +3.7%3.5%3.1 $4.09 8/15/20233,490,000 shares $13.66 million -3.6%3.4%3 $3.92 7/31/20233,620,000 shares $11.58 million -12.8%3.6%3.3 $3.20 7/15/20234,150,000 shares $12.57 million +0.2%4.1%4 $3.03 6/30/20234,140,000 shares $12.83 million -4.6%4.1%3.9 $3.10 6/15/20234,340,000 shares $11.72 million -13.6%4.3%4.4 $2.70 5/31/20235,020,000 shares $11.75 million +7.3%4.9%5.3 $2.34 5/15/20234,680,000 shares $9.45 million -24.8%4.6%4.9 $2.02 4/30/20236,220,000 shares $12.00 million -9.9%6.3%6.2 $1.93 4/15/20236,900,000 shares $9.38 million +7.1%6.9%6.3 $1.36 3/31/20236,440,000 shares $8.95 million -13.1%6.5%6.1 $1.39 3/15/20237,410,000 shares $10.08 million +4.1%8.9%6.6 $1.36Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/28/20237,120,000 shares $14.67 million -11.7%7.2%5.5 $2.06 2/15/20238,060,000 shares $20.23 million -11.5%8.1%6.6 $2.51 1/31/20239,110,000 shares $20.04 million +10.6%9.1%7.1 $2.20 1/15/20238,240,000 shares $18.29 million +6.5%8.3%7.1 $2.22 12/30/20227,740,000 shares $15.40 million +142.6%7.8%6.8 $1.99 12/15/20223,190,000 shares $7.24 million -12.6%3.3%2.9 $2.27 11/30/20223,650,000 shares $9.34 million -15.3%3.8%3.5 $2.56 11/15/20224,310,000 shares $9.91 million -7.9%4.5%4.4 $2.30 10/31/20224,680,000 shares $10.30 million -2.9%4.8%4 $2.20 10/15/20224,820,000 shares $9.45 million +2.6%5.0%4.3 $1.96 9/30/20224,700,000 shares $9.49 million +2.2%4.8%4.3 $2.02 9/15/20224,600,000 shares $10.81 million +15.3%4.7%4.3 $2.35 8/31/20223,990,000 shares $8.66 million +7.3%4.1%3.9 $2.17 8/15/20223,720,000 shares $11.87 million +9.4%3.8%4.1 $3.19 7/31/20223,400,000 shares $12.04 million -6.6%3.5%4.9 $3.54 7/15/20223,640,000 shares $11.39 million -3.7%3.8%5.3 $3.13 6/30/20223,780,000 shares $12.02 million -9.1%3.9%5.1 $3.18 6/15/20224,160,000 shares $13.98 million -1.0%4.6%5.6 $3.36 5/31/20224,200,000 shares $15.25 million +7.7%4.4%5.6 $3.63 5/15/20223,900,000 shares $13.46 million +3.7%4.0%5.1 $3.45 4/30/20223,760,000 shares $14.51 million +10.3%3.9%5 $3.86 4/15/20223,410,000 shares $14.05 million +6.9%3.5%5 $4.12 3/31/20223,190,000 shares $13.30 million -0.9%3.3%5 $4.17 3/15/20223,220,000 shares $12.78 million +9.9%3.4%4.9 $3.97 2/28/20222,930,000 shares $13.27 million +1.0%3.1%4.5 $4.53 2/15/20222,900,000 shares $13.72 million +30.0%3.0%4.4 $4.73 1/31/20222,230,000 shares $9.88 million +4.7%2.3%3.2 $4.43 1/15/20222,130,000 shares $9.88 million -19.3%2.2%2.8 $4.64 12/31/20212,640,000 shares $12.65 million -6.7%2.8%3.4 $4.79 12/15/20212,830,000 shares $11.72 million +8.0%3.0%3.4 $4.14 11/30/20212,620,000 shares $10.95 million -15.2%2.7%3.1 $4.18 11/15/20213,090,000 shares $15.94 million -3.7%3.2%3.1 $5.16 10/29/20213,210,000 shares $17.62 million -5.3%3.4%3.1 $5.49 10/15/20213,390,000 shares $19.12 million -5.8%3.5%3.5 $5.64 9/30/20213,600,000 shares $19.22 million -10.9%3.8%3.3 $5.34 9/15/20214,040,000 shares $20.00 million -9.2%4.2%3.7 $4.95 8/31/20214,450,000 shares $25.10 million -2.4%4.7%4.3 $5.64 8/13/20214,560,000 shares $23.30 million -4.4%4.8%5.7 $5.11 7/30/20214,770,000 shares $23.52 million -0.6%5.0%5.6 $4.93 7/15/20214,800,000 shares $20.93 million +12.4%5.0%5.4 $4.36 6/30/20214,270,000 shares $21.86 million -5.3%4.5%5 $5.12 6/15/20214,510,000 shares $25.71 million -0.4%4.7%4.8 $5.70 5/28/20214,530,000 shares $25.64 million +2.0%4.8%3.7 $5.66 5/14/20214,440,000 shares $24.33 million -31.2%4.7%2.3 $5.48 4/30/20216,450,000 shares $36.57 million +57.7%6.8%3.2 $5.67 4/15/20214,090,000 shares $23.80 million +29.4%4.3%2 $5.82 3/31/20213,160,000 shares $21.05 million -43.6%3.3%1.5 $6.66 3/15/20215,600,000 shares $33.71 million +2.8%5.9%2.8 $6.02 2/26/20215,450,000 shares $26.65 million -9.9%5.8%3.1 $4.89 2/12/20216,050,000 shares $35.70 million +21.2%6.4%5.1 $5.90Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 1/29/20214,990,000 shares $24.60 million -18.1%5.3%4.2 $4.93 1/15/20216,090,000 shares $29.54 million +19.4%6.4%5.2 $4.85 12/31/20205,100,000 shares $23.46 million -21.9%5.4%4.3 $4.60 12/15/20206,530,000 shares $28.67 million +2.5%6.9%5.7 $4.39 11/30/20206,370,000 shares $25.93 million -3.6%6.7%5.5 $4.07 11/15/20206,610,000 shares $27.37 million +7.0%7.0%5.6 $4.14 10/30/20206,180,000 shares $26.94 million -1.3%6.5%5.4 $4.36 10/15/20206,260,000 shares $30.61 million -12.7%6.6%5.5 $4.89 9/30/20207,170,000 shares $27.82 million -4.5%7.6%6.3 $3.88 9/15/20207,510,000 shares $30.34 million +8.7%8.0%6.4 $4.04 8/31/20206,910,000 shares $28.40 million -0.1%7.3%5.5 $4.11 8/14/20206,920,000 shares $29.41 million -3.4%7.3%4.9 $4.25 7/31/20207,160,000 shares $31.00 million +2.6%7.6%4.2 $4.33 7/15/20206,980,000 shares $32.60 million -5.6%7.4%4.2 $4.67 6/30/20207,390,000 shares $35.18 million +26.8%7.8%4.3 $4.76 6/15/20205,830,000 shares $25.42 million -4.3%6.2%3 $4.36 5/29/20206,090,000 shares $29.48 million -9.2%6.5%2.8 $4.84 5/15/20206,710,000 shares $27.65 million No Change7.1%3 $4.12 4/30/20206,710,000 shares $24.36 million +4.7%7.1%3.2 $3.63 4/15/20206,410,000 shares $21.54 million +2.9%6.8%3.5 $3.36 3/31/20206,230,000 shares $19.94 million +17.6%6.6%3.3 $3.20 3/13/20205,296,700 shares $17.59 million +20.7%4.7%2 $3.32 2/28/20204,390,000 shares $16.73 million +20.3%4.9%1.6 $3.81 2/14/20203,650,000 shares $11.61 million -7.4%4.4%1.3 $3.18 1/31/20203,940,000 shares $15.17 million -27.3%4.8%1.4 $3.85 1/15/20205,420,000 shares $27.32 million +9.3%6.6%1.8 $5.04 12/31/20194,960,000 shares $23.46 million -13.9%6.0%1.7 $4.73 AMRX Short Interest - Frequently Asked Questions What is Amneal Pharmaceuticals' current short interest? Short interest is the volume of Amneal Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 4,670,000 shares of AMRX short. 3.69% of Amneal Pharmaceuticals' shares are currently sold short. Learn More on Amneal Pharmaceuticals' current short interest. What is a good short interest ratio for Amneal Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMRX shares currently have a short interest ratio of 4.0. Learn More on Amneal Pharmaceuticals's short interest ratio. What is a good short interest percentage for Amneal Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.69% of Amneal Pharmaceuticals' floating shares are currently sold short. Is Amneal Pharmaceuticals' short interest increasing or decreasing? Amneal Pharmaceuticals saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 4,670,000 shares, an increase of 4.2% from the previous total of 4,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amneal Pharmaceuticals' float size? Amneal Pharmaceuticals currently has issued a total of 309,844,000 shares. Some of Amneal Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amneal Pharmaceuticals currently has a public float of 126,530,000 shares. How does Amneal Pharmaceuticals' short interest compare to its competitors? 3.69% of Amneal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Amneal Pharmaceuticals: Intra-Cellular Therapies, Inc. (1.64%), Roivant Sciences Ltd. (12.55%), Ascendis Pharma A/S (6.22%), Revolution Medicines, Inc. (9.61%), Lantheus Holdings, Inc. (6.73%), Nuvalent, Inc. (12.26%), Legend Biotech Co. (13.04%), Blueprint Medicines Co. (6.60%), Elanco Animal Health Incorporated (3.15%), Cytokinetics, Incorporated (12.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Amneal Pharmaceuticals stock? Short selling AMRX is an investing strategy that aims to generate trading profit from Amneal Pharmaceuticals as its price is falling. AMRX shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amneal Pharmaceuticals? A short squeeze for Amneal Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMRX, which in turn drives the price of the stock up even further. How often is Amneal Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMRX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Intra-Cellular Therapies Short Interest Data Roivant Sciences Short Interest Data Ascendis Pharma A/S Short Interest Data Revolution Medicines Short Interest Data Lantheus Short Interest Data Nuvalent Short Interest Data Legend Biotech Short Interest Data Blueprint Medicines Short Interest Data Elanco Animal Health Short Interest Data Cytokinetics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMRX Stock Alerts